Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.570
-0.040 (-1.53%)
Nov 4, 2024, 4:00 PM EST - Market closed
Nautilus Biotechnology Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$4.50
Upside
+75.10%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +133.46% | Jun 27, 2024 |
Jefferies | Jefferies | Strong Buy → Hold Initiates $5 → $3 | Strong Buy → Hold | Initiates | $5 → $3 | +16.73% | Jun 3, 2024 |
Morgan Stanley | Morgan Stanley | Hold Reiterates $6 | Hold | Reiterates | $6 | +133.46% | Aug 3, 2023 |
Morgan Stanley | Morgan Stanley | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +133.46% | Aug 3, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $4 → $2 | Hold | Maintains | $4 → $2 | -22.18% | Aug 3, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | +55.64% | Jul 14, 2022 |
Goldman Sachs | Goldman Sachs | Hold Maintains $9 → $5 | Hold | Maintains | $9 → $5 | +94.55% | Apr 13, 2022 |
Morgan Stanley | Morgan Stanley | Hold Initiates $8 | Hold | Initiates | $8 | +211.28% | Jan 6, 2022 |
Cowen & Co. | Cowen & Co. | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Nov 2, 2021 |
Goldman Sachs | Goldman Sachs | Hold Initiates $10 | Hold | Initiates | $10 | +289.11% | Aug 4, 2021 |
Jefferies | Jefferies | Strong Buy Initiates $13 | Strong Buy | Initiates | $13 | +405.84% | Jul 13, 2021 |